Virus Expression Database

GSE159191

SARS-CoV-2 infected cells present HLA-I peptides from canonical and out-of-frame ORFs

Submitted by Shira Weingarten-Gabbay (Weizmann Institute Of Science, Israel) on Oct 07 2020

Platform: ngs – NextSeq 550 (Homo sapiens)

Pubmed: None listed

Summary T cell-mediated immunity seems to play a critical role against SARS-CoV-2 infection and establishing protective memory. Yet the repertoire of viral epitopes responsible for activation of T cell responses remains mostly unknown. Identification and characterization of viral peptides presented on class I human leukocyte antigen (HLA-I) will reveal the viral signatures as seen by cytotoxic T cells that can then be harnessed for the development of effective vaccines. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two human cell lines at different times post-infection using mass spectrometry. We found HLA-I peptides derived not only from canonical ORFs, but also from internal out-of-frame ORFs in Spike and Nucleoprotein not currently captured by vaccine approaches. Whole proteome analysis revealed that expression of ubiquitination pathway proteins, and the proteasome maturation protein, POMP, were significantly altered in infected cells. Retrospective analysis of computational predictions highlighted shortcomings of in silico-only approaches in recovering the observed viral epitopes. Finally, given the experimental evidence for endogenous processing and presentation of the viral peptides we detected, we estimated that at least one HLA-A, -B, or -C allele is covered by at least one peptide for 99% of the population. These biological insights and the list of naturally presented SARS-CoV-2 peptides will facilitate data-driven selection of peptides for immune monitoring and vaccine development.

16 Samples

ID Title Cell Type Timepoint Reported Virus Virus Species Exclusion Reason
GSM4822344 A549 non-infecetd non-small cell lung adenocarcinoma cell line  [A-549 ] non-infected Uninfected
GSM4822345 A549 12h post infection non-small cell lung adenocarcinoma cell line  [A-549 ] 12 hrs SARS-CoV-2 Severe acute respiratory syndrome-related coronavirus
GSM4822346 A549 18h post infection non-small cell lung adenocarcinoma cell line  [A-549 ] 18 hrs SARS-CoV-2 Severe acute respiratory syndrome-related coronavirus
GSM4822347 A549 24h post infection non-small cell lung adenocarcinoma cell line  [A-549 ] 24 hrs SARS-CoV-2 Severe acute respiratory syndrome-related coronavirus
GSM4822348 HEK293T non-infecetd Rep1 embryonic kidney cell line  [HEK293T ] non-infected Uninfected
GSM4822349 HEK293T non-infecetd Rep2 embryonic kidney cell line  [HEK293T ] non-infected Uninfected
GSM4822350 HEK293T non-infecetd Rep3 embryonic kidney cell line  [HEK293T ] non-infected Uninfected
GSM4822351 HEK293T 12h post infection Rep1 embryonic kidney cell line  [HEK293T ] 12 hrs SARS-CoV-2 Severe acute respiratory syndrome-related coronavirus
GSM4822352 HEK293T 12h post infection Rep2 embryonic kidney cell line  [HEK293T ] 12 hrs SARS-CoV-2 Severe acute respiratory syndrome-related coronavirus
GSM4822353 HEK293T 12h post infection Rep3 embryonic kidney cell line  [HEK293T ] 12 hrs SARS-CoV-2 Severe acute respiratory syndrome-related coronavirus
GSM4822354 HEK293T 18h post infection Rep1 embryonic kidney cell line  [HEK293T ] 18 hrs SARS-CoV-2 Severe acute respiratory syndrome-related coronavirus
GSM4822355 HEK293T 18h post infection Rep2 embryonic kidney cell line  [HEK293T ] 18 hrs SARS-CoV-2 Severe acute respiratory syndrome-related coronavirus
GSM4822356 HEK293T 18h post infection Rep3 embryonic kidney cell line  [HEK293T ] 18 hrs SARS-CoV-2 Severe acute respiratory syndrome-related coronavirus
GSM4822357 HEK293T 24h post infection Rep1 embryonic kidney cell line  [HEK293T ] 24 hrs SARS-CoV-2 Severe acute respiratory syndrome-related coronavirus
GSM4822358 HEK293T 24h post infection Rep2 embryonic kidney cell line  [HEK293T ] 24 hrs SARS-CoV-2 Severe acute respiratory syndrome-related coronavirus
GSM4822359 HEK293T 24h post infection Rep3 embryonic kidney cell line  [HEK293T ] 24 hrs SARS-CoV-2 Severe acute respiratory syndrome-related coronavirus